pI: 6.7517 |
Length (AA): 1005 |
MW (Da): 112952 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_126779)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G65750 | 2-oxoglutarate dehydrogenase, E1 component |
Arabidopsis thaliana | AT3G55410 | 2-oxoglutarate dehydrogenase, E1 component |
Babesia bovis | BBOV_I002070 | 2-oxoglutarate dehydrogenase E1 component, putative |
Brugia malayi | Bm1_31540 | 2-oxoglutarate dehydrogenase E1 component, mitochondrial precursor |
Candida albicans | CaO19.6165 | 2-Oxoglutarate dehydrogenase complex E1 component |
Caenorhabditis elegans | CELE_T22B11.5 | Protein OGDH-1 |
Caenorhabditis elegans | CELE_ZK836.2 | Protein ZK836.2, isoform B |
Chlamydia trachomatis | CT_054 | oxoglutarate dehydrogenase |
Dictyostelium discoideum | DDB_G0280353 | 2-oxoglutarate dehydrogenase E1 component |
Dictyostelium discoideum | DDB_G0288127 | 2-oxoglutarate dehydrogenase, E1 subunit |
Drosophila melanogaster | Dmel_CG1544 | CG1544 gene product from transcript CG1544-RA |
Drosophila melanogaster | Dmel_CG11661 | Neural conserved at 73EF |
Drosophila melanogaster | Dmel_CG33791 | CG33791 gene product from transcript CG33791-RB |
Escherichia coli | b0726 | 2-oxoglutarate decarboxylase, thiamine triphosphate-binding |
Echinococcus granulosus | EgrG_000429700 | 2 oxoglutarate dehydrogenase |
Echinococcus multilocularis | EmuJ_000429700 | 2 oxoglutarate dehydrogenase |
Homo sapiens | ENSG00000197444 | oxoglutarate dehydrogenase-like |
Homo sapiens | ENSG00000181192 | dehydrogenase E1 and transketolase domain containing 1 |
Homo sapiens | ENSG00000105953 | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
Leishmania braziliensis | LbrM.35.3700 | 2-oxoglutarate dehydrogenase E1 component, putative |
Leishmania braziliensis | LbrM.27.0960 | 2-oxoglutarate dehydrogenase subunit, putative |
Leishmania donovani | LdBPK_270740.1 | 2-oxoglutarate dehydrogenase subunit, putative |
Leishmania donovani | LdBPK_363630.1 | 2-oxoglutarate dehydrogenase E1 component, putative |
Leishmania infantum | LinJ.27.0740 | 2-oxoglutarate dehydrogenase subunit, putative |
Leishmania infantum | LinJ.36.3630 | 2-oxoglutarate dehydrogenase E1 component, putative |
Leishmania major | LmjF.36.3470 | 2-oxoglutarate dehydrogenase E1 component, putative |
Leishmania major | LmjF.27.0880 | 2-oxoglutarate dehydrogenase subunit, putative |
Leishmania mexicana | LmxM.36.3470 | 2-oxoglutarate dehydrogenase E1 component, putative |
Leishmania mexicana | LmxM.27.0880 | 2-oxoglutarate dehydrogenase subunit, putative |
Loa Loa (eye worm) | LOAG_02520 | 2-oxoglutarate dehydrogenase E1 component |
Mycobacterium leprae | ML1095c | PROBABLE 2-OXOGLUTARATE DEHYDROGENASE SUCA (Alpha-ketoglutarate dehydrogenase) |
Mus musculus | ENSMUSG00000025815 | dehydrogenase E1 and transketolase domain containing 1 |
Mus musculus | ENSMUSG00000020456 | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
Mus musculus | ENSMUSG00000021913 | oxoglutarate dehydrogenase-like |
Mycobacterium tuberculosis | Rv1248c | Multifunctional alpha-ketoglutarate metabolic enzyme |
Mycobacterium ulcerans | MUL_4500 | alpha-ketoglutarate decarboxylase |
Neospora caninum | NCLIV_018800 | hypothetical protein |
Oryza sativa | 4344403 | Os07g0695800 |
Oryza sativa | 4335673 | Os04g0390000 |
Onchocerca volvulus | OVOC11286 |
|
Plasmodium berghei | PBANKA_0710100 | 2-oxoglutarate dehydrogenase E1 component, putative |
Plasmodium falciparum | PF3D7_0820700 | 2-oxoglutarate dehydrogenase E1 component |
Plasmodium knowlesi | PKNH_1314700 | 2-oxoglutarate dehydrogenase E1 component, putative |
Plasmodium vivax | PVX_089325 | 2-oxoglutarate dehydrogenase E1 component, mitochondrial precursor, putative |
Plasmodium yoelii | PY02421 | 2-oxoglutarate dehydrogenase, E1 component |
Saccharomyces cerevisiae | YIL125W | alpha-ketoglutarate dehydrogenase KGD1 |
Schistosoma japonicum | Sjp_0073030 | ko:K00164 2-oxoglutarate dehydrogenase E1 component [EC1.2.4.2], putative |
Schistosoma mansoni | Smp_044970 | 2-oxoglutarate dehydrogenase |
Schmidtea mediterranea | mk4.000452.05 | Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial |
Schmidtea mediterranea | mk4.001673.03 | 2-oxoglutarate dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.000452.06 | |
Schmidtea mediterranea | mk4.001673.04 | 2-oxoglutarate dehydrogenase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.11.11200 | 2-oxoglutarate dehydrogenase E1 component, putative |
Trypanosoma brucei gambiense | Tbg972.11.1540 | 2-oxoglutarate dehydrogenase subunit, putative |
Trypanosoma brucei | Tb927.11.1450 | 2-oxoglutarate dehydrogenase E1 component, putative |
Trypanosoma brucei | Tb927.11.9980 | 2-oxoglutarate dehydrogenase E1 component, putative |
Trypanosoma congolense | TcIL3000.11.1340 | 2-oxoglutarate dehydrogenase subunit, putative |
Trypanosoma cruzi | TcCLB.506337.70 | 2-oxoglutarate dehydrogenase E1 component, putative |
Trypanosoma cruzi | TcCLB.510797.10 | 2-oxoglutarate dehydrogenase subunit, putative |
Trypanosoma cruzi | TcCLB.503793.10 | 2-oxoglutarate dehydrogenase subunit, putative |
Trypanosoma cruzi | TcCLB.510717.30 | 2-oxoglutarate dehydrogenase E1 component, putative |
Toxoplasma gondii | TGME49_244200 | 2-oxoglutarate dehydrogenase e1 component, mitochondrial precursor, putative |
Theileria parva | TP03_0124 | 2-oxoglutarate dehydrogenase e1 component, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0395 | 2-oxoglutarate dehydrogenase E1 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1740 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1740 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1740 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.1740 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.47.0004 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.47.0004 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.47.0004 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.47.0004 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0726 | Escherichia coli | essential | goodall |
CELE_T22B11.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T22B11.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T22B11.5 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T22B11.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T22B11.5 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0710100 | Plasmodium berghei | Dispensable | plasmo |
TGME49_244200 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.